Epidemiology, clinical characteristics, household transmission, and lethality of severe acute respiratory syndrome coronavirus-2 infection among healthcare workers in Ontario, Canada.
Journal
PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081
Informations de publication
Date de publication:
2020
2020
Historique:
received:
19
06
2020
accepted:
10
12
2020
entrez:
28
12
2020
pubmed:
29
12
2020
medline:
12
1
2021
Statut:
epublish
Résumé
Protecting healthcare workers (HCWs) from Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) is a priority to maintain a safe and functioning healthcare system. Our objective was to describe and compare the epidemiology, clinical characteristics, and lethality of SARS-CoV-2 infections among HCWs compared to non-HCWs. Using reportable disease data at Public Health Ontario, we conducted a population-based cross-sectional study comparing demographic, exposure, and clinical variables between HCWs and non-HCWs with SARS-CoV-2 infections as of 30 September 2020. We calculated rates of infections over time and determined the frequency of within household transmissions using natural language processing based on residential address. We evaluated the risk of death using a multivariable logistic regression model adjusting for age, sex, comorbidities, symptoms, and long-term care home exposure. There were 7,050 (12.5%) HCW SARS-CoV-2 infections in Ontario, Canada, of whom 24.9% were nurses, 2.3% were physicians, and the remaining 72.8% other specialties, including personal support workers. Overall HCWs had an infection rate of 1,276 per 100,000 compared to non-HCWs of 346 per 100,000 (3.7 times higher). This difference decreased from a 7 times higher rate in April to no difference in September 2020. Twenty-six percent of HCWs had a household member with SARS-CoV-2 infection; 6.8% were probable acquisitions, 12.3% secondary transmissions, and 6.9% unknown direction of transmission. Death among HCWs was 0.2% compared to 6.1% of non-HCWs. The risk of death in HCWs remained significantly lower than non-HCWs after adjustment (adjusted odds ratio 0.09; 95%CI 0.05-0.17). HCWs represent a disproportionate number of diagnosed SARS-CoV-2 infections in Ontario, however this discrepancy is at least partially explained by limitations in testing earlier in the pandemic for non-HCWs. We observed a low risk of death in HCWs which could not be completely explained by other factors.
Identifiants
pubmed: 33370384
doi: 10.1371/journal.pone.0244477
pii: PONE-D-20-18932
pmc: PMC7769426
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
e0244477Déclaration de conflit d'intérêts
The authors have declared that no competing interests exist.
Références
Infect Control Hosp Epidemiol. 2020 May;41(5):493-498
pubmed: 32131908
Infect Control Hosp Epidemiol. 2021 Apr;42(4):381-387
pubmed: 32900402
Lancet Infect Dis. 2020 Dec;20(12):1401-1408
pubmed: 32758438
Clin Infect Dis. 2020 Nov 5;71(8):1943-1946
pubmed: 32301964
N Engl J Med. 2020 Apr 30;382(18):1708-1720
pubmed: 32109013
JAMA Intern Med. 2020 Dec 1;180(12):1707-1709
pubmed: 32780100
Clin Infect Dis. 2021 Jul 1;73(1):e199-e205
pubmed: 32986118
JAMA. 2020 Apr 14;323(14):1335
pubmed: 32181795
JAMA Netw Open. 2020 May 1;3(5):e209673
pubmed: 32437576
China CDC Wkly. 2020 Feb 21;2(8):113-122
pubmed: 34594836
Lancet. 2020 May 2;395(10234):e77-e78
pubmed: 32333843
JAMA Netw Open. 2020 Mar 2;3(3):e203976
pubmed: 32202646
JAMA. 2020 Jul 14;324(2):195-197
pubmed: 32539107
Ann Intern Med. 2020 Jul 21;173(2):120-136
pubmed: 32369541
JAMA. 2020 May 19;323(19):1915-1923
pubmed: 32275295
JAMA. 2020 Mar 17;323(11):1061-1069
pubmed: 32031570
Nat Commun. 2020 Oct 8;11(1):5064
pubmed: 33033249
Ann Intern Med. 2020 Jun 2;172(11):766-767
pubmed: 32176257
MMWR Morb Mortal Wkly Rep. 2020 Oct 30;69(43):1576-1583
pubmed: 33119554
MMWR Morb Mortal Wkly Rep. 2020 Apr 17;69(15):477-481
pubmed: 32298247
MMWR Morb Mortal Wkly Rep. 2020 Mar 27;69(12):339-342
pubmed: 32214083
JAMA Netw Open. 2020 May 1;3(5):e209666
pubmed: 32437575
JAMA Intern Med. 2020 Sep 1;180(9):1156-1163
pubmed: 32356867